Alkermes

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

person helping another drink soup

Responsible Business & Employee Engagement | Alkermes

Supporting Employees Beyond the Workplace – For Our People and for Our Business

It’s no surprise that a rising number of employees are reporting burnout from the demands of work and home, especially as a rapidly aging population requires increased levels of care.

Flexible Media Releases

Supporting Employees Beyond the Workplace – For Our People and for Our Business

Alkermes' Company Culture Built On Foundation of Compassion, Science

Celebrating Black Mental Health Trailblazers

Alkermes Celebrates Employee Volunteerism Throughout 2022

How Is the Brain Affected by Alcohol?

Alkermes and Corporate Responsibility: Our Guiding Principles

Alkermes & the Environment - 2021 Performance Highlights

Alkermes' Approach to Environmental Protection and Sustainability

Former Oncology Nurse Finds a New Path To Improve Patients' Lives

47% of Adults With Alcohol Use Disorder Sought Help Because of Family Encouragement

Patient Advocacy at Alkermes

Alkermes Celebrates Giving Tuesday With Volunteering Efforts

Ohio Alkermes Site Named Among Healthiest Employers in the State

Alkermes Supporting Local Communities

Equal Opportunity and Respect at Alkermes

Campaigns

Alkermes Inspiration Grants®
Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive...

Alkermes: Corporate Responsibility
We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...

Alkermes: Diversity, Inclusion & Belonging
Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...

Alkermes Medicines & Focus: Cancer
We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...

Alkermes Medicines & Focus: Serious Mental Illness
We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...

Alkermes Medicines & Focus: Addiction
We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...

Videos

Contact Alkermes
open_in_new
Alkermes